Donglu Zhao

机构：Harbin Medical University, Harbin Institute of Technology, First Affiliated Hospital of Harbin Medical University

发表论文 34 篇 · 总被引 379 次 · h-index 8

代表论文

• Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019 (2022 · Aging · 被引 47)
• A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China (2021 · Frontiers in Oncology · 被引 22)
• Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study (2025 · 癌症：英文版 · 被引 15)
• LINC00265/miR-4500 Axis Accelerates Acute Lymphoblastic Leukemia Progression by Enhancing STAT3 Signals (2021 · Cancer Management and Research · 被引 10)
• Chinese expert consensus on Bruton tyrosine kinase inhibitors in the treatment of B-cell malignancies (2023 · Experimental Hematology and Oncology · 被引 8)
• Cost–effectiveness of obinutuzumab plus bendamustine in Chinese patients with relapse and refractory follicular lymphoma (2023 · Journal of Comparative Effectiveness Research · 被引 5)